Combination of radiotherapy and immune treatment: First clinical data

Cancer radiothérapie : journal de la Société française de radiothérapie oncologique
Dirk De Ruysscher

Abstract

There is a very strong biological and pre-clinical rationale for combining radiotherapy with immune treatment. Radiation affects all steps in the immune response to antigens and clearly upregulates key-molecules on the cancer cell and in the tumor micro-environment, such as MHC class I antigens, tumor-associated antigens and the creation of neo-antigens as well. In many pre-clinical models, radiation together with the right combination and timing of immune therapy leads to regression of distant metastases, at remote non-irradiated sites of the body, the so-called "abscopal effects". The combination generally also increases the local tumor control. Although a plethora of clinical trials are ongoing or are being planned, clinical data are sparse and mostly even retrospective. The few published prospective studies nevertheless support a synergy between radiotherapy and immune treatment. At least with checkpoint inhibitors, the side effects of the combined modality treatment do not seem to be significantly higher than of each modality alone. In the coming years, more solid data will surely appear and it is anticipated that radiotherapy will become an integral part of immune therapy.

Citations

Apr 11, 2020·International Journal of Molecular Sciences·Achamaporn PunnanitinontSantosh K Patnaik
Dec 1, 2020·International Journal of Cancer. Journal International Du Cancer·Pushpamali De SilvaCinzia Solinas
Jan 12, 2021·Human Vaccines & Immunotherapeutics·Chen ChenBinbin Cui
Feb 13, 2020·Cancer radiothérapie : journal de la Société française de radiothérapie oncologique·L M AbbassiY M Kirova

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.